Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'human xenografts' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 250 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Jung, LL; Zamboni, WC
      Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?

      DRUG RESISTANCE UPDATES
    2. Komatsu, T; Yamazaki, H; Shimada, N; Nagayama, S; Kawaguchi, Y; Nakajima, M; Yokoi, T
      Involvement of microsomal cytochrome P450 and cytosolic thymidine phosphorylase in 5-fluorouracil formation from tegafur in human liver

      CLINICAL CANCER RESEARCH
    3. Khokhar, NZ; She, Y; Rusch, VW; Sirotnak, FM
      Experimental therapeutics with a new 10-deazaaminopterin in human mesothelioma: Further improving efficacy through structural design, pharmacologic modulation at the level of MRP ATPases, and combined therapy with platinums

      CLINICAL CANCER RESEARCH
    4. Guichard, S; Montazeri, A; Chatelut, E; Hennebelle, I; Bugat, R; Canal, P
      Schedule-dependent activity of topotecan in OVCAR-3 ovarian carcinoma xenograft: Pharmacokinetic and pharmacodynamic evaluation

      CLINICAL CANCER RESEARCH
    5. Stromberg, I; Tornqvist, N; Johansson, S; Bygdeman, M; Almqvist, PM
      Evidence for target-specific outgrowth from subpopulations of grafted human dopamine neurons

      MICROSCOPY RESEARCH AND TECHNIQUE
    6. Kruczynski, A; Hill, BT
      Vinflunine, the latest Vinca alkaloid in clinical development - A review of its preclinical anticancer properties

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    7. Bonasera, TA; Ortu, G; Rozen, Y; Krais, R; Freedman, NMT; Chisin, R; Gazit, A; Levitzki, A; Mishani, E
      Potential F-18-labeled biomarkers for epidermal growth factor receptor tyrosine kinase

      NUCLEAR MEDICINE AND BIOLOGY
    8. Johnston, PG; Kaye, S
      Capecitabine: a novel agent for the treatment of solid tumors

      ANTI-CANCER DRUGS
    9. Pratesi, G; Monestiroli, SV
      Preclinical evaluation of new anthracyclines

      CURRENT MEDICINAL CHEMISTRY
    10. Perego, P; Corna, E; De Cesare, M; Gatti, L; Polizzi, D; Pratesi, G; Supino, R; Zunino, F
      Role of apoptosis and apoptosis-related genes in cellular response and antitumor efficacy of anthracyclines

      CURRENT MEDICINAL CHEMISTRY
    11. Abe, S; Kubota, T; Otani, Y; Furukawa, T; Watanabe, M; Kumai, K; Akiyama, T; Akinaga, S; Kitajima, M
      UCN-01 (7-hydoxystaurosporine) inhibits in vivo growth of human cancer cells through selective perturbation of G1 phase checkpoint machinery

      JAPANESE JOURNAL OF CANCER RESEARCH
    12. Tsukamoto, Y; Kato, Y; Ura, M; Horii, I; Ishitsuka, H; Kusuhara, H; Sugiyama, Y
      A physiologically based pharmacokinetic analysis of capecitabine, a tripleprodrug of 5-FU, in humans: The mechanism for tumor-selective accumulationof 5-FU

      PHARMACEUTICAL RESEARCH
    13. Chastagner, P; Kozin, SV; Taghian, A
      Topotecan selectively enhances the radioresponse of human small-cell lung carcinoma and glioblastoma multiforme xenografts in nude mice

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    14. Hunjan, S; Zhao, DW; Constantinescu, A; Hahn, EW; Antich, PP; Mason, RP
      Tumor oximetry: Demonstration of an enhanced dynamic mapping procedure using fluorine-19 echo planar magnetic resonance imaging in the Dunning prostate R3327-AT1 rat tumor

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    15. Klecker, RW; Collins, JM
      Thymidine phosphorylase as a target for imaging and therapy with thymine analogs

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    16. Struck, RF; Tiwari, A; Friedman, HS; Keir, S; Morgan, LR; Waud, WR
      Acyl derivatives of demethylpenclomedine, an antitumor-active, non-neurotoxic metabolite of penclomedine

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    17. Keir, ST; Hausheer, F; Lawless, AA; Bigner, DD; Friedman, HS
      Therapeutic activity of 7-[(2-trimethylsilyl)ethyl)]-20 (S)-camptothecin against central nervous system tumor-derived xenografts in athymic mice

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    18. Riccardi, A; Meco, D; Ferlini, C; Servidei, T; Carelli, G; Segni, G; Manzotti, C; Riccardi, R
      In vitro and in vivo antitumor activity of the novel trinuclear platinum complex BBR 3464 in neuroblastoma

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    19. Stuben, G; Thews, O; Pottgen, C; Knuhmann, K; Vaupel, P; Stuschke, M
      Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    20. Jain, RK
      Delivery of molecular and cellular medicine to solid tumors

      ADVANCED DRUG DELIVERY REVIEWS
    21. Jain, RK
      Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function

      JOURNAL OF CONTROLLED RELEASE
    22. Baumann, M; Petersen, C; Wolf, J; Schreiber, A; Zips, D
      No evidence for a different magnitude of the time factor for continuously fractionated irradiation and protocols including gaps in two human squamouscell carcinoma in nude mice

      RADIOTHERAPY AND ONCOLOGY
    23. de Bono, JS; Twelves, CJ
      The oral fluorinated pyrimidines

      INVESTIGATIONAL NEW DRUGS
    24. Dienel, GA; Popp, D; Drew, PD; Ball, K; Krisht, A; Cruz, NF
      Preferential labeling of glial and meningial brain tumors with [2-C-14]acetate

      JOURNAL OF NUCLEAR MEDICINE
    25. Zhao, DW; Constantinescu, A; Hahn, EW; Mason, RP
      Tumor oxygen dynamics with respect to growth and respiratory challenge: Investigation of the Dunning prostate R3327-HI tumor

      RADIATION RESEARCH
    26. Supino, R; Polizzi, D; Pavesi, R; Pratesi, G; Guano, F; Capranico, G; Palumbo, M; Sissi, C; Richter, S; Beggiolin, G; Menta, E; Pezzoni, G; Spinelli, S; Torriani, D; Carenini, N; Dal Bo, L; Facchinetti, F; Tortereto, M; Zunino, F
      A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenografts

      ONCOLOGY
    27. Stephen, AE; Masiakos, PT; Segev, DL; Vacanti, JP; Donahoe, PK; MacLaughlin, DT
      Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    28. Burger, AM; Hartung, G; Stehle, G; Sinn, H; Fiebig, HH
      Pre-clinical evaluation of a methotrexate-albumin conjugate (MTX-HSA) in human tumor xenografts in vivo

      INTERNATIONAL JOURNAL OF CANCER
    29. Cassinelli, G; Supino, R; Perego, P; Polizzi, D; Lanzi, C; Pratesi, G; Zunino, F
      A role for loss of p53 function in sensitivity of ovarian carcinoma cells to taxanes

      INTERNATIONAL JOURNAL OF CANCER
    30. Morita, T; Mitsuzaki, A; Tokue, A
      Enhancement of sensitivity to capecitabine in human renal carcinoma cells transfected with thymidine phosphorylase cDNA

      INTERNATIONAL JOURNAL OF CANCER
    31. West, CML; Cooper, RA; Loncaster, JA; Wilks, DP; Bromley, M
      Tumor vascularity: A histological measure of angiogenesis and hypoxia

      CANCER RESEARCH
    32. De Cesare, M; Pratesi, G; Perego, P; Carenini, N; Tinelli, S; Merlini, L; Penco, S; Pisano, C; Bucci, F; Vesci, L; Pace, S; Capocasa, F; Carminati, P; Zunino, F
      Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecin

      CANCER RESEARCH
    33. Cokgor, I; Akabani, G; Friedman, HS; Friedman, AH; Zalutsky, MR; Zehngebot, LM; Provenzale, JM; Guy, CD; Wikstrand, CJ; Bigner, DD
      Long term response in a patient with neoplastic meningitis secondary to melanoma treated with I-131-radiolabeled antichondroitin proteoglycan sulfateMel-14 F(ab ')(2) - A case study

      CANCER
    34. Watanabe, Y; Koi, M; Hemmi, H; Hoshai, H; Noda, K
      A change in microsatellite instability caused by cisplatin-based chemotherapy of ovarian cancer

      BRITISH JOURNAL OF CANCER
    35. Marchetti, S; Chazal, M; Dubreuil, A; Fischell, JL; Etienne, MC; Milano, G
      Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesis

      BRITISH JOURNAL OF CANCER
    36. Burger, AM; Mengs, U; Schuler, JB; Fiebig, HH
      Antiproliferative activity of an aqueous mistletoe extract in human tumor cell lines and xenografts in vitro

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    37. Buma, P; Groenenberg, M; Rijken, PFJW; van den Berg, WB; Joosten, L; Peters, H
      Quantitation of the changes in vascularity during arthritis in the knee joint of a mouse with a digital image analysis system

      ANATOMICAL RECORD
    38. Sabel, MS; Conway, TF; Chen, FA; Bankert, RB
      Monoclonal antibodies directed against the T-cell activation molecule CD137 (interleukin-A or 4-1BB) block human lymphocyte-mediated suppression of tumor xenografts in severe combined immunodeficient mice

      JOURNAL OF IMMUNOTHERAPY
    39. Geoerger, B; Tang, CB; Cesano, A; Visonneau, S; Marwaha, S; Judy, KD; Sutton, LN; Santoli, D; Phillips, PC
      Antitumor activity of a human cytotoxic T-cell line (TALL-104) in brain tumor xenografts

      NEURO-ONCOLOGY
    40. Zalutsky, MR; Vaidyanathan, G
      Astatine-211-labeled radiotherapeutics: An emerging approach to targeted alpha-particle radiotherapy

      CURRENT PHARMACEUTICAL DESIGN
    41. Krug, LM; Ng, KK; Kris, MG; Miller, VA; Tong, W; Heelan, RT; Leon, L; Leung, D; Kelly, J; Sirotnak, FM
      Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate

      CLINICAL CANCER RESEARCH
    42. Polizzi, D; Pratesi, G; Monestiroli, S; Tortoreto, M; Zunino, F; Bombardelli, E; Riva, A; Morazzoni, P; Colombo, T; D'Incalci, M; Zucchetti, M
      Oral efficacy and bioavailability of a novel taxane

      CLINICAL CANCER RESEARCH
    43. Kang, N; Hamilton, S; Odili, J; Wilson, G; Kupsch, J
      In vivo targeting of malignant melanoma by (125)iodine- and (99m)technetium-labeled single-chain Fv fragments against high molecular weight melanoma-associated antigen

      CLINICAL CANCER RESEARCH
    44. Buchsbaum, DJ
      Experimental radioimmunotherapy

      SEMINARS IN RADIATION ONCOLOGY
    45. Padron, JM; van der Wilt, CL; Smid, K; Smitskamp-Wilms, E; Backus, HHJ; Pizao, PE; Giaccone, G; Peters, GJ
      The multilayered postconfluent cell culture as a model for drug screening

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    46. Mori, K; Hasegawa, M; Nishida, M; Toma, H; Fukuda, M; Kubota, T; Nagasue, N; Yamana, H; Chung, KHY; Ikeda, T; Takasaki, K; Oka, M; Kameyama, M; Toi, M; Fujii, H; Kitamura, M; Murai, M; Sasaki, H; Ozono, S; Makuuchi, H; Shimada, Y; Onishi, Y; Aoyagi, S; Mizutani, K; Ogawa, M; Nakao, A; Kinoshita, H; Tono, T; Imamoto, H; Nakashima, Y; Manabe, T
      Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues

      INTERNATIONAL JOURNAL OF ONCOLOGY
    47. Liu, CN; Ferdinandi, ES; Ely, G; Joshi, SS
      Virulizin (R)-2 gamma, a novel immunotherapeutic agent, in treatment of human pancreatic cancer xenografts

      INTERNATIONAL JOURNAL OF ONCOLOGY
    48. Shimma, N; Umeda, I; Arasaki, M; Murasaki, C; Masubuchi, K; Kohchi, Y; Miwa, M; Ura, M; Sawada, N; Tahara, H; Kuruma, I; Horii, I; Ishitsuka, H
      The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, capecitabine

      BIOORGANIC & MEDICINAL CHEMISTRY
    49. Kamm, YJL; Heerschap, A; Wagener, DJT
      Effect of carbogen breathing on the pharmacodynamics of 5-fluorouracil in a murine colon carcinoma

      EUROPEAN JOURNAL OF CANCER
    50. Fiebig, HH; Dengler, W; Hendriks, HR
      No evidence of tumor growth stimulation in human tumors in vitro followingtreatment with recombinant human growth hormone

      ANTI-CANCER DRUGS
    51. Schilsky, RL
      Pharmacology and clinical status of capecitabine

      ONCOLOGY-NEW YORK
    52. Pavlinkova, G; Colcher, D; Booth, BJM; Goel, A; Batra, SK
      Pharmacokinetics and biodistribution of a light-chain-shuffled CC49 single-chain Fv antibody construct

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    53. Rohde, D; Wiesner, C; Graf, D; Wolff, J; Fuzesi, L; Jakse, G
      Interstitial fluid pressure is increased in renal cell carcinoma xenografts

      UROLOGICAL RESEARCH
    54. van der Sanden, BPJ; Rozijn, TH; Rijken, PFJW; Peters, HPW; Heerschap, A; van der Kogel, AJ; Bovee, WMMJ
      Noninvasive assessment of the functional neovasculature in 9L-glioma growing in rat brain by dynamic H-1 magnetic resonance imaging of gadolinium uptake

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    55. Brekken, C; Bruland, OS; Davies, CD
      Interstitial fluid pressure in human osteosarcoma xenografts: Significanceof implantation site and the response to intratumoral injection of hyaluronidase

      ANTICANCER RESEARCH
    56. Brekken, C; Hjelstuen, MH; Bruland, OS; Davies, CD
      Hyaluronidase-induced periodic modulation of the interstitial fluid pressure increases selective antibody uptake in human osteosarcoma xenografts

      ANTICANCER RESEARCH
    57. Yang, J; Liu, A; Dougherty, C; Chen, XY; Guzman, R; Nandi, S
      Beware of contaminating mouse cells in human xenografts from nude mice

      ANTICANCER RESEARCH
    58. Bussink, J; Kaanders, JHAM; Strik, AM; van der Kogel, AJ
      Effects of nicotinamide and carbogen on oxygenation in human tumor xenografts measured with luminescense based fiber-optic probes

      RADIOTHERAPY AND ONCOLOGY
    59. Ishitsuka, H
      Capecitabine: preclinical pharmacology studies

      INVESTIGATIONAL NEW DRUGS
    60. Budman, DR
      Capecitabine

      INVESTIGATIONAL NEW DRUGS
    61. Reilly, RM; Kiarash, R; Sandhu, J; Lee, YW; Cameron, RG; Hendler, A; Vallis, K; Gariepy, J
      A comparison of EGF and MAb 528 labeled with In-111 for imaging human breast cancer

      JOURNAL OF NUCLEAR MEDICINE
    62. Harstrick, A
      Future treatment options with capecitabine

      SEMINARS IN ONCOLOGY
    63. McBride, AA; Dlugosz, A; Baker, CC
      Production of infectious bovine papillomavirus from cloned viral DNA by using an organotypic raft/xenograft technique

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    64. Tomera, JF
      Mesothelioma: Drug treatment and other interventions

      DRUGS OF TODAY
    65. Jeuken, JWM; Sprenger, SHE; Wesseling, P; Bernsen, HJJA; Suijkerbuijk, RF; Roelofs, F; Macville, MVE; Gilhuis, HJ; van Overbeeke, JJ; Boerman, RH
      Genetic reflection of glioblastoma biopsy material in xenografts: characterization of 11 glioblastoma xenograft lines by comparative genomic hybridization

      JOURNAL OF NEUROSURGERY
    66. Figgitt, DP; Wiseman, LR
      Docetaxel - An update of its use in advanced breast cancer

      DRUGS
    67. Cusack, JC; Liu, R; Baldwin, AS
      Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappa B activation

      CANCER RESEARCH
    68. Zhou, R; Bansal, N; Leeper, DB; Glickson, JD
      Intracellular acidification of human melanoma xenografts by the respiratory inhibitor m-iodobenzylguanidine plus hyperglycemia: A P-31 magnetic resonance spectroscopy study

      CANCER RESEARCH
    69. Kolfschoten, GM; Hulscher, TM; Pinedo, HM; Boven, E
      Drug resistance features and S-phase fraction as possible determinants fordrug response in a panel of human ovarian cancer xenografts

      BRITISH JOURNAL OF CANCER
    70. Kruczynski, A; Etievant, C; Perrin, D; Imbert, T; Colpaert, F; Hill, BT
      Preclinical antitumour activity of F 11782, a novel dual catalytic inhibitor of topoisomerases

      BRITISH JOURNAL OF CANCER
    71. Pratesi, G; Polizzi, D; Perego, P; Dal Bo, L; Zunino, F
      Bcl-2 phosphorylation in a human breast carcinoma xenograft: A common event in response to effective DNA-damaging drugs

      BIOCHEMICAL PHARMACOLOGY
    72. Jain, RK
      Transport of molecules, particles, and cells in solid tumors

      ANNUAL REVIEW OF BIOMEDICAL ENGINEERING
    73. Zunino, F; Cassinelli, G; Polizzi, D; Perego, P
      Molecular mechanisms of resistance to taxanes and therapeutic implications

      DRUG RESISTANCE UPDATES
    74. Line, BR; Feustel, PJ; Festin, SM; Andersen, TT; Dansereau, RN; Lukasiewicz, RL; Zhu, SJ; Bennett, JA
      Scintigraphic detection of breast cancer xenografts with Tc-99m natural and recombinant human alpha-fetoprotein

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    75. Mattern, J; Koomagi, R; Volm, M
      Biological characterization of subgroups of squamous cell lung carcinomas

      CLINICAL CANCER RESEARCH
    76. Sandstrom, P; Johansson, A; Ullen, A; Rathsman, S; Riklund-Ahlstrom, K; Stigbrand, T
      Idiotypic-anti-idiotypic antibody interactions in experimental radioimmunotargeting

      CLINICAL CANCER RESEARCH
    77. Boven, E; Jansen, WJM; Hulscher, TM; Beijnen, JH; van Tellingen, O
      The influence of P170-glycoprotein modulators on the efficacy and the distribution of vincristine as well as on MDR1 expression in BRO/mdr1.1 human melanoma xenografts

      EUROPEAN JOURNAL OF CANCER
    78. Hendriks, HR; Fiebig, HH; Giavazzi, R; Langdon, SP; Jimeno, JM; Faircloth, GT
      High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer

      ANNALS OF ONCOLOGY
    79. Votruba, I; Krecmerova, M; Hrebabecky, H; Holy, A
      Inhibitory potency of 5-benzyluracil, 5-phenylcytosine and 5-phenylpyrimidin-2-one nucleosides against uridine phosphorylase from mouse leukemic L1210 cells

      NUCLEOSIDES & NUCLEOTIDES
    80. Furman, WL; Stewart, CF; Poquette, CA; Pratt, CB; Santana, VM; Zamboni, WC; Bowman, LC; Ma, MK; Hoffer, FA; Meyer, WH; Pappo, AS; Walter, AW; Houghton, PJ
      Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children

      JOURNAL OF CLINICAL ONCOLOGY
    81. Olsen, DR; Singstad, TE; Rofstad, EK
      Effects of hyperthermia on bioenergetic status and phosphorus T1S in humanmelanoma xenografts monitored by P-31-MRS

      MAGNETIC RESONANCE IMAGING
    82. Morita, T; Tokue, A
      Biomodulation of 5-fluorouracil by interferon-alpha in human renal carcinoma cells: relationship to the expression of thymidine phosphorylase

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    83. Kinuya, S; Yokoyama, K; Hiramatsu, T; Tega, H; Tanaka, K; Konishi, S; Shuke, N; Aburano, T; Watanabe, N; Takayama, T; Michigishi, T; Tonami, N
      Combination radioimmunotherapy with local hyperthermia: increased deliveryof radioimmunoconjugate by vascular effect and its retention by increased antigen expression in colon cancer xenografts

      CANCER LETTERS
    84. Taghian, AG; Suit, HD
      Animal systems for translational research in radiation oncology

      ACTA ONCOLOGICA
    85. Senekowitsch-Schmidtke, R
      Binding of EGF peptide and EGF receptor antibodies and its fragments in different tumor models

      HYBRIDOMA
    86. Howard, RB; Mullen, JBM; Pagura, ME; Johnston, MR
      Characterization of a highly metastatic, orthotopic lung cancer model in the nude rat

      CLINICAL & EXPERIMENTAL METASTASIS
    87. Klein, HO; Demir, G
      "Multi-enzyme-targeted" immunochemotherapy: A salvage therapy protocol

      ANTICANCER RESEARCH
    88. Hardman, WE; Moyer, MP; Cameron, IL
      Efficacy of treatment of colon, lung and breast human carcinoma xenograftswith: Doxorubicin, cisplatin, irinotecan or topotecan

      ANTICANCER RESEARCH
    89. Stausbol-Gron, B; Overgaard, J
      Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck

      RADIOTHERAPY AND ONCOLOGY
    90. Baumann, M; Petersen, C; Schulz, P; Baisch, H
      Impact of overall treatment time on local control of slow growing human GLsquamous cell carcinoma in nude mice treated by fractionated irradiation

      RADIOTHERAPY AND ONCOLOGY
    91. Bernsen, HJJA; Van der Kogel, AJ
      Antiangiogenic therapy in brain tumor models

      JOURNAL OF NEURO-ONCOLOGY
    92. Takeda, N; Diksic, M
      Relationship between drug delivery and the intra-arterial infusion rate ofSarCNU in C6 rat brain tumor model

      JOURNAL OF NEURO-ONCOLOGY
    93. Ishitsuka, H; Shimma, N; Horii, I
      Discovery and development of novel anticancer drug capecitabine

      YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
    94. Verweij, J
      Rational design of new Tumoractivated (TM) cytotoxic agents

      ONCOLOGY
    95. Yip, YL; Hawkins, NJ; Smith, G; Ward, RL
      Biodistribution of filamentous phage-Fab in nude mice

      JOURNAL OF IMMUNOLOGICAL METHODS
    96. Endo, M; Shinbori, N; Fukase, Y; Sawada, N; Ishikawa, T; Ishitsuka, H; Tanaka, Y
      Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5 '-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models

      INTERNATIONAL JOURNAL OF CANCER
    97. Dooley, M; Goa, KL
      Capecitabine

      DRUGS
    98. Dahlberg, WK; Azzam, EI; Yu, YJ; Little, JB
      Response of human tumor cells of varying radiosensitivity and radiocurability to fractionated irradiation

      CANCER RESEARCH
    99. Holst-Hansen, C; Hamers, MJAG; Johannessen, BE; Brunner, N; Stephens, RW
      Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies

      BRITISH JOURNAL OF CANCER
    100. Boland, I; Vassal, G; Morizet, J; Terrier-Lacombe, MJ; Valteau-Couanet, D; Kalifa, C; Hartmann, O; Gouyette, A
      Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations

      BRITISH JOURNAL OF CANCER


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 12:23:10